Chaos and uncertainty are our words of the moment. At Capita3, we view this period of disruption as an opportunity to identify truly transformative innovations and founders with the grit to navigate these complex waters.

NextSense is building a neurotech platform that is initially focused on sleep enhancement technologies for the growing consumer sleep tech market, The Company is addressing the need for accessible, noninvasive, and efficacious sleep monitoring and sleep enhancement solutions.

The Company is a leader in the growing field of microbiome-based medicine, which is exploring how the trillions of microorganisms in our bodies influence our health and how they might be leveraged for better medical treatments.

In this 90 day reprieve on the higher tariffs for all but China, we, like most investors, are working with our existing companies and prospective investments to understand the potential impact of tariffs…

Actress, Joylux investor and strategic brand partner - Halle Berry - was featured on  Oprah's special, alongside a panel of medical experts and leading voices to discuss the traditionally taboo topic of menopause…

2025 is already off to a great start, with groundbreaking healthcare advancements lighting up the industry…

Paterna Bioscienceis a biotech company focused on the rapidly growing $20B+infertility market…

Many of us are caregivers for our elderly parents or sick family members. If you've been a caregiver, you know the time and energy that goes into this labor of love…

The care economy is one of the largest segments of care in the world. A recent report by Columbia University Mailman School of Public Health, and sponsored by Otsuka says…

Our portfolio company teams have skillfully navigated the ever-shifting market landscape, fostering both growth and resilience…

Gabbi is an emerging leader in breast cancer screening and detection markets, focusing on early risk assessment and care…

We have some initial predictions on how the new administration will impact the venture capital and healthcare industries…

HLTH2024, one of the largest and most important healthcare conferences of the year, took place October 20 - 23 in Las Vegas, NV….

Capita3 Fund II & IIA portfolio company Claros Technologies announced yesterday the completion of the first successful pilot…

We know that women-founded companies demonstrate 35% better returns and 2x more revenue per dollar invested than their male counterparts, yet these entrepreneurs continue to face significant challenges when raising capital…

For us, the top 2024 event was the Recast Capital Summit in Sonoma. This was a venture capital emerging manager event set in California’s wine country…

In the realm of asset allocation, what role do investments in venture capital funds and emerging managers play? Capita3 had the opportunity to speak with key opinion leaders in institutional asset allocation…

We are cautiously optimistic the liquidity market is rebounding. This optimism is balance by the election cycle, which will likely create market volatility but overall we are bullish…

The groundbreaking impact of AI and machine learning in advancing healthcare diagnostics is truly remarkable…

Claros Technologies, Inc. (ClarosTech™), the leader in PFAS analytical and destruction technologies, announced today that it has raised $22M

Capita3 Funds I, II, and IIA are aimed at the intersection of digital health and deep tech, where hugely underserved sectors relative to their potential are opening up…

Portfolio company EmpowerU Inc. was acquired by FullBloom, a leader in early-intervention and evidence-based education and behavioral health solutions that create better life outcomes for children and their families…

MDisrupt, the leading expert marketplace for the healthtech industry, is excited to announce the successful completion of a $3 million seed…